Johnson Chemical Pharmaceutical Works Co Ltd (4747.TWO) stock: key figures, P/E, revenue and dividend

Health Care · Pharmaceuticals · Taiwan · ISIN TW0004747001

Price
15.40 TWD
Market cap
1.40 bn TWD
P/E (2025)
26.12
P/S (2025)
2.46
Dividend yield
3.41 %
Net margin
9.39 %
Return on equity (ROE)
3.13 %
Return on assets (ROA)
2.56 %

Johnson Chemical Pharmaceutical Works Co Ltd financials

Fiscal year20242025
Revenue611.42 m TWD569.77 m TWD
Gross profit247.97 m TWD228.35 m TWD
Operating income98.00 m TWD73.11 m TWD
EBIT112.21 m TWD67.12 m TWD
Net income84.12 m TWD53.51 m TWD
Diluted EPS – continuing operations0.94 TWD0.59 TWD

Full history since 2009, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Johnson Chemical Pharmaceutical Works Co Ltd

Johnson Chemical Pharmaceutical Works Co., Ltd. manufactures, imports, and sells pharmaceutical ingredients, materials and products in Taiwan. The company manufactures drugs in a variety of forms, such as solid dosage form, capsule, tablet, and powder and granule, as well as nasal spray forms. It offers its products in various therapeutic areas, including central nervous system, respiratory, cardiovascular, gastrointestinal, endocrine system, vitamins, anti-inflammatory, cough and cold, pain reliever, etc. The company was founded in 1959 and is based in New Taipei City, Taiwan.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 16.11.2026. Details in the risk notice.